The global biosimulation market size was valued at USD 3.5 billion in 2024, with North America holding a substantial market share. The market is driven by technological advancements in biosimulation software, which enable researchers to create computer models of biological systems. These models are crucial for understanding diseases, drug development, and personalized treatments. The North...